Chemours Co Annual Income Tax Expense (Benefit) in USD from 2013 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Chemours Co quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2013 to 2023.
  • Chemours Co Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was -$3M, a 400% decline year-over-year.
  • Chemours Co Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was -$29M.
  • Chemours Co annual Income Tax Expense (Benefit) for 2023 was -$81M, a 150% decline from 2022.
  • Chemours Co annual Income Tax Expense (Benefit) for 2022 was $163M, a 140% increase from 2021.
  • Chemours Co annual Income Tax Expense (Benefit) for 2021 was $68M.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$81M -$244M -150% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-27
2022 $163M +$95M +140% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-27
2021 $68M +$108M Jan 1, 2021 Dec 31, 2021 10-K 2024-03-27
2020 -$40M +$32M +44.4% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-10
2019 -$72M -$231M -145% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-11
2018 $159M -$6M -3.64% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-12
2017 $165M +$183M Jan 1, 2017 Dec 31, 2017 10-K 2020-02-14
2016 -$18M +$80M +81.6% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-15
2015 -$98M -$247M -166% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-16
2014 $149M -$3M -1.97% Jan 1, 2014 Dec 31, 2014 10-K 2017-02-17
2013 $152M Jan 1, 2013 Dec 31, 2013 10-K 2016-02-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.